Ribose (Furanose)

Ribose (Furanose)

SCHEMBL3976341

O=c1[nH]cc(F)c(=O)[nH]1.OC[C@H]1OC(O)[C@H](O)[C@@H]1O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TYMS

The experimentally established mechanism targets of Ribose (Furanose). The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 2/20 0.54
MAPT P10636 1/20 0.54
CYP19A1 P11511 1/20 0.54
TSHR P16473 1/20 0.54
THPO P40225 1/20 0.54
MTOR P42345 1/20 0.54
HTT P42858 1/20 0.54
HBB P68871 1/20 0.54
PMP22 Q01453 1/20 0.54
PYGM P11217 3/20 0.38
SLC28A1 O00337 1/20 0.37
SLC28A2 O43868 1/20 0.37
SLC29A1 Q99808 1/20 0.37
SLC28A3 Q9HAS3 1/20 0.37
GBA1 P04062 1/20 0.36
PNP P00491 1/20 0.36
ATM Q13315 1/20 0.35
TK2 O00142 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribose (Furanose) SCHEMBL2056776 1.00 LMNA (0.54) LMNASMN1; SMN2ALDH1A1MAPTCYP19A1
Ribose (Furanose) SCHEMBL5521544 0.83 ATAD2 (0.54) LMNAALDH1A1PYGMSLC28A1SLC28A2
Ribose (Furanose) SCHEMBL27814247 0.83 DPYD (0.54) LMNAALDH1A1MAPTPYGMSLC28A1
Ribose (Furanose) SCHEMBL1851842 0.83 ATAD2 (0.54) LMNAALDH1A1PYGMSLC28A1SLC28A2
D-Galactose SCHEMBL16581344 0.82 ATAD2 (0.53) ALDH1A1PYGMATM
Dextrose SCHEMBL6692229 0.82 ATAD2 (0.53) ALDH1A1PYGMATM
Ribose (Furanose) SCHEMBL9621710 0.82 SLC5A2 (0.39) ALDH1A1PYGMSLC28A1SLC28A2SLC29A1
5-Fluorouridine SCHEMBL6441323 0.81 PYGM (0.60) LMNASMN1; SMN2MAPTTSHRHBB
Fluorouracil SCHEMBL8778444 0.80 LMNA (0.51) LMNASMN1; SMN2ALDH1A1MAPTCYP19A1
Fluorouracil SCHEMBL4289411 0.80 LMNA (0.50) LMNASMN1; SMN2ALDH1A1MAPTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104398519-A Advanced cancer treatment method FENG BAOZHANG 2015-03-11 CN disclosed
WO-2009058800-A2 SYNTHESIS OF NUCLEOSIDES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-05-07 WO disclosed
US-20050079222-A1 Production of nanoparticles from methyl vinyl ether and maleic anhydride for the administration of hydrophilic pharmaceuticals, more particularly of puric and pyrimidinic bases INSTITUTO CIENTIFICO Y TECNOLOGICO DE NAVARRA, S.A. (ES) 2005-04-14 US disclosed
EP-1369110-A1 PRODUCTION OF NANOPARTICLES FROM METHYL VINYL ETHER COPOLYMER AND MALEIC ANHYDRIDE FOR THE ADMINISTRATION OF HYDROPHILIC PHARMACEUTICALS, MORE PARTICULARLY OF PURIC AND PYRIMIDINIC BASES INSTITUTO CIENTIFICO Y TECNOLOGICO DE NAVARRA, S.A. (ES) 2003-12-10 EP disclosed
EP-0630904-A1 NOVEL NICOTINE DERIVATIVE JAPAN TOBACCO INC. (JP) 1994-12-28 EP disclosed
EP-0628567-A1 NICOTINE DERIVATIVE JAPAN TOBACCO INC. (JP) 1994-12-14 EP disclosed
US-3879260-A Process for production of ribosides of nucleic acid base derivatives and analogues thereof ASAHI CHEMICAL IND 1975-04-22 US disclosed